Core Insights - The company reported a consolidated revenue of HKD 9.452 billion for the first three quarters of 2025, representing a 10% increase compared to the same period last year [1] - The company's attributable profit decreased by 6% year-on-year to HKD 109 million [1] Segment Performance - The food biotechnology segment generated revenue of HKD 7.836 billion, an 11% increase year-on-year, but the segment profit (excluding share of associates) fell by 12% to HKD 138 million [1] - The company maintained its slaughtering operations in the Greater Bay Area, with a live pig slaughter volume of approximately 2.34 million heads, but faced a decline in operating profit due to intensified regional competition and price adjustments [1] - The market share for live pigs supplied to Hong Kong decreased to 48% from 49% year-on-year, leading to a reduction in profits from the live pig distribution business [1] - The company is expanding its food wholesale and retail operations in Hong Kong, currently operating 19 retail stores [1] - The performance of the joint venture in live pig breeding and sales slowed down due to falling pig prices in the third quarter, with the company's share of profits from associates amounting to HKD 18.91 million [1] - After accounting for the share of profits from associates, the segment profit for food biotechnology was HKD 157 million, a decrease of HKD 8.92 million or 5% year-on-year [1]
广南(集团)(01203.HK)首三季度综合收入94.52亿港元 同比增加10%